U.S. patent application number 16/427443 was filed with the patent office on 2019-09-19 for apparatuses, systems, and methods for managing liquid flow associated with a tissue site using the presence of reduced pressure.
The applicant listed for this patent is KCI Licensing, Inc.. Invention is credited to Christopher Brian LOCKE, Aidan Marcus TOUT.
Application Number | 20190282739 16/427443 |
Document ID | / |
Family ID | 42285809 |
Filed Date | 2019-09-19 |
![](/patent/app/20190282739/US20190282739A1-20190919-D00000.png)
![](/patent/app/20190282739/US20190282739A1-20190919-D00001.png)
![](/patent/app/20190282739/US20190282739A1-20190919-D00002.png)
![](/patent/app/20190282739/US20190282739A1-20190919-D00003.png)
![](/patent/app/20190282739/US20190282739A1-20190919-D00004.png)
United States Patent
Application |
20190282739 |
Kind Code |
A1 |
TOUT; Aidan Marcus ; et
al. |
September 19, 2019 |
APPARATUSES, SYSTEMS, AND METHODS FOR MANAGING LIQUID FLOW
ASSOCIATED WITH A TISSUE SITE USING THE PRESENCE OF REDUCED
PRESSURE
Abstract
The illustrative embodiments described herein are directed to
apparatuses, systems, and methods for managing liquid flow
associated with a tissue site that involves using reduced pressure
to control fluid flow. In one instance, an apparatus includes a
first valve and a second valve in fluid communication with a
reduced-pressure source. The valves are movable between an open
position and a closed position and are operable to change flow
status (open to closed or vice versa) based on a presence of
reduced pressure. At least one of the first valve or the second
valve is in the closed position to obstruct a flow of a liquid
while the other is in the open position. The apparatus also
includes a reservoir fluidly coupled to the first valve and the
second valve. Other systems, methods, and apparatuses are
presented.
Inventors: |
TOUT; Aidan Marcus;
(Alderbury, GB) ; LOCKE; Christopher Brian;
(Bournemouth, GB) |
|
Applicant: |
Name |
City |
State |
Country |
Type |
KCI Licensing, Inc. |
San Antonio |
TX |
US |
|
|
Family ID: |
42285809 |
Appl. No.: |
16/427443 |
Filed: |
May 31, 2019 |
Related U.S. Patent Documents
|
|
|
|
|
|
Application
Number |
Filing Date |
Patent Number |
|
|
15478068 |
Apr 3, 2017 |
10350338 |
|
|
16427443 |
|
|
|
|
14285404 |
May 22, 2014 |
9656007 |
|
|
15478068 |
|
|
|
|
13931089 |
Jun 28, 2013 |
8771240 |
|
|
14285404 |
|
|
|
|
12640511 |
Dec 17, 2009 |
8491540 |
|
|
13931089 |
|
|
|
|
61141609 |
Dec 30, 2008 |
|
|
|
Current U.S.
Class: |
1/1 |
Current CPC
Class: |
A61M 1/0033 20140204;
Y10T 29/49236 20150115; A61M 2207/00 20130101; A61M 1/0058
20130101; A61M 1/0088 20130101; A61M 1/0035 20140204; A61M 1/0031
20130101; A61M 1/0037 20130101; A61M 39/22 20130101 |
International
Class: |
A61M 1/00 20060101
A61M001/00; A61M 39/22 20060101 A61M039/22 |
Claims
1. An apparatus for managing a liquid flow associated with a tissue
site, the apparatus comprising: a first valve movable between an
open position and a closed position, wherein the first valve is
configured to be activated based on a reduced pressure transmitted
from the tissue site to the first valve; a second valve movable
between an open position and a closed position, wherein the second
valve is configured to be activated based on a reduced pressure
transmitted from the tissue site to the second valve; and wherein
the first valve is configured to be in the open position when the
second valve is in the closed position, and wherein the first valve
is configured to be in the closed position when the second valve is
in the open position.
2. The apparatus of claim 1, wherein the first valve is configured
to move from the open position to the closed position in an absence
of the reduced pressure at the first valve; and wherein the second
valve is configured to move from the open position to the closed
position in the presence of the reduced pressure at the second
valve.
3. The apparatus of claim 1, wherein the first valve is configured
to move from the closed position to the open position in the
presence of the reduced pressure at the first valve; wherein the
first valve is configured to move from the open position to the
closed position in an absence of the reduced pressure at the first
valve; wherein the second valve is configured to move from the open
position to the closed position in the presence of the reduced
pressure at the second valve; and wherein the second valve is
configured to move from the closed position to the open position in
an absence of the reduced pressure at the second valve.
4. The apparatus of claim 1, further comprising a reservoir
disposed in fluid communication between the first valve and the
second valve, the reservoir configured to contain a liquid when one
of the first valve or the second valve is in the closed
position.
5. The apparatus of claim 4, further comprising a set of
restriction strips configured to restrict expansion of the
reservoir to contain a maximum amount of liquid, wherein the set of
restriction strips are disposed over at least a portion of the
reservoir.
6. The apparatus of claim 4, further comprising a set of
restriction strips configured to restrict expansion of the
reservoir to contain a maximum amount of liquid, wherein the set of
restriction strips are disposed over at least a portion of the
reservoir, and wherein each of the set of restriction strips is
removable from the reservoir to increase the maximum amount of the
liquid holdable by the reservoir.
7. The apparatus of claim 1, further comprising at least one
reduced-pressure conduit configured to transmit the reduced
pressure from the tissue site to the first valve and the second
valve.
8. The apparatus of claim 4, further comprising at least one
reduced-pressure conduit configured to transmit the reduced
pressure from the tissue site to the first valve and the second
valve, the apparatus further comprising a first sheet and a second
sheet coupled to the first sheet to at least partially form the
reservoir and the reduced-pressure conduit.
9. The apparatus of claim 8, wherein the reservoir and the
reduced-pressure conduit are at least partially formed by abutting
portions of the first sheet and the second sheet, or by welding at
least a portion of the first sheet to the second sheet.
10. The apparatus of claim 8, further comprising a foam member
disposed between the first sheet and the second sheet, wherein the
foam member is configured to transfer the reduced pressure and the
liquid.
11. The apparatus of claim 10, wherein at least a portion of the
foam member is included in the reduced-pressure conduit.
12. The apparatus of claim 11, wherein a first end of the foam
member forms at least a portion of the first valve.
13. The apparatus of claim 12, wherein the first end of the foam
member is an enlarged end portion; and wherein the first end of the
foam member compresses in the presence of reduced pressure.
14. The apparatus of claim 8, further comprising a third sheet
coupled to the second sheet to form an inlet conduit, wherein the
inlet conduit is configured to transfer the liquid to the
reservoir.
15. The apparatus of claim 4, further comprising at least one
reduced-pressure conduit configured to transmit the reduced
pressure from the tissue site to the first valve and the second
valve, the apparatus further comprising: a first sheet; a second
sheet coupled to the first sheet to at least partially form the
reservoir and the reduced-pressure conduit; a foam member disposed
between the first sheet and the second sheet, wherein the foam
member is configured to transfer the reduced pressure and the
liquid; wherein at least a portion of the foam member is included
in the reduced-pressure conduit; wherein a first end of the foam
member forms at least a portion of the first valve; wherein the
second valve comprises a first wall and a second wall, wherein the
first wall is a portion of the first sheet, and wherein the second
wall is a portion of the second sheet; wherein the first wall and
the second wall are configured to draw nearer to one another in the
presence of reduced pressure to form the closed position; and
wherein the first wall and the second wall are configured to move
away from one another in an absence of reduced pressure to form the
open position.
16. The apparatus of claim 1, wherein the first valve and the
second valve are pilot-actuated valves.
17. The apparatus of claim 1, wherein the reduced pressure is
received by the first valve and the second valve.
Description
RELATED APPLICATIONS
[0001] This application is a continuation of U.S. patent
application Ser. No. 15/478,068, filed Apr. 3, 2017, which is a
continuation of U.S. patent application Ser. No. 14/285,404, filed
May 22, 2014, now U.S. Pat. No. 9,656,007, which is a division of
U.S. patent application Ser. No. 13/931,089, filed Jun. 28, 2013,
now U.S. Pat. No. 8,771,240, which is a division of U.S. patent
application Ser. No. 12/640,511, filed Dec. 17, 2009, now U.S. Pat.
No. 8,491,540, which claims the benefit, under 35 U.S.C. .sctn.
119(e), of the filing of U.S. Provisional Patent Application Ser.
No. 61/141,609 entitled "Apparatuses, Systems, and Methods for
Managing Liquid flow Associated with a Tissue Site Based on the
Presence of Reduced Pressure," filed Dec. 30, 2008, each of which
are incorporated herein by reference for all purposes.
BACKGROUND
[0002] Clinical studies and practice have shown that providing a
reduced pressure in proximity to a tissue site augments and
accelerates the growth of new tissue at the tissue site. The
applications of this phenomenon are numerous, but application of
reduced pressure has been particularly successful in treating
wounds. This treatment (frequently referred to in the medical
community as "negative pressure wound therapy," "reduced pressure
therapy," or "vacuum therapy") provides a number of benefits,
including faster healing, and increased formulation of granulation
tissue.
SUMMARY
[0003] To alleviate existing problems with medical treatment
systems, the illustrative embodiments described herein are directed
to apparatuses, systems, and methods for managing liquid flow
associated with a tissue site. According to an illustrative,
non-limiting embodiment, a system for managing liquid flow
associated with a tissue site includes a liquid source operable to
supply liquid, a reduced-pressure source operable to supply reduced
pressure, and a first valve in fluid communication with the
reduced-pressure source. The first valve is movable between an open
position and a closed position and is operable to be activated
based on a presence of reduced pressure. The system further
includes a second valve in fluid communication with the
reduced-pressure source. The second valve is also movable between
an open position and a closed position and is operable to be
activated based on the presence of reduced pressure. At least one
of the first valve and the second valve is in the closed position
to obstruct a flow of a liquid when under reduced pressure. The
system further includes a reservoir fluidly coupled to the first
valve and the second valve. The reservoir is operable to contain
liquid from the liquid source. The system further includes a first
delivery conduit that is in fluid communication with the reservoir
and is operable to deliver the liquid from the liquid source. The
system also includes a second delivery conduit that is in fluid
communication with the reservoir and is operable to deliver the
liquid from the reservoir to the tissue site.
[0004] According to another illustrative, non-limiting embodiment,
an apparatus for managing liquid flow associated with a tissue site
includes a first valve in fluid communication with a
reduced-pressure source. The first valve is movable between an open
position and a closed position and is operable to be activated
based on a presence of reduced pressure. The apparatus further
includes a second valve in fluid communication with the
reduced-pressure source. The second valve is movable between an
open position and a closed position and is operable to be activated
based on the presence of reduced pressure. At least one of the
first valve and the second valve is in the closed position to
obstruct a flow of liquid when experiencing reduced pressure. The
apparatus also includes a reservoir fluidly coupled to the first
valve and the second valve. The reservoir is operable to receive
liquid from a liquid source when the first valve is in the open
position.
[0005] According to another illustrative, non-limiting embodiment,
a method for managing liquid flow associated with a tissue site
includes providing a valve arrangement having a first valve, a
second valve, and a reservoir, and receiving reduced pressure at
the first valve and the second valve. The first valve and second
valve each have an open position and a closed position. The method
further includes changing a flow status (open to closed or vice
versa) of the first valve in response to receiving reduced pressure
at the first valve, receiving a liquid at the reservoir when the
first valve is open, changing a flow status of the second valve in
response to receiving reduced pressure at the second valve, and
obstructing a flow of liquid from the reservoir when the second
valve is closed.
[0006] According to another illustrative, non-limiting embodiment,
a method for managing liquid flow associated with a tissue site
includes providing a valve arrangement with a first valve, a second
valve, and a reservoir. The method also includes fluidly coupling
the first valve to a liquid source, fluidly coupling the second
valve to the tissue site, changing a position of the first valve to
one of an open position and a closed position based on a presence
of reduced pressure at the first valve, and changing a position of
the second valve to the other of the open position and the closed
position based on a presence of reduced pressure at the second
valve.
[0007] According to another illustrative, non-limiting embodiment,
a method of manufacturing an apparatus for managing liquid flow
associated with a tissue site includes providing a first valve
moveable between an open position and a closed position and
operable to change flow status based on a presence of reduced
pressure, providing a second valve moveable between an open
position and a closed position and operable to change flow status
based on the presence of reduced pressure, and providing a
reservoir operable to contain a liquid. The method further includes
coupling the reservoir to the first valve and the second valve such
that the reservoir is disposed between the first valve and the
second valve.
[0008] According to another illustrative, non-limiting embodiment,
a method of manufacturing an apparatus for managing liquid flow
associated with a tissue site includes providing a first sheet,
providing a second sheet, providing a foam member, and coupling the
first sheet to the second sheet to form a reduced-pressure conduit,
a reservoir, a first valve, and a second valve. The foam member is
enclosed between the first sheet and the second sheet.
[0009] Other features and advantages of the illustrative,
non-limiting embodiments will become apparent with reference to the
drawings and detailed description that follow.
BRIEF DESCRIPTION OF THE DRAWINGS
[0010] A more complete understanding may be obtained by reference
to the following Detailed Description when taken in conjunction
with the accompanying Drawings, wherein like numerals indicate like
elements throughout, and wherein:
[0011] FIG. 1 is a schematic diagram of a treatment system for
managing liquid flow associated with a tissue site in accordance
with an illustrative embodiment;
[0012] FIG. 2 is a schematic, perspective view of an apparatus for
managing liquid flow associated with a tissue site in accordance
with an illustrative embodiment;
[0013] FIG. 3 is a schematic, exploded perspective view of an
apparatus for managing liquid flow associated with a tissue site in
accordance with an illustrative embodiment;
[0014] FIG. 4 is a schematic cross-sectional view of the apparatus
of FIG. 2 taken along line 4-4 when at least a portion of the
apparatus is exposed to reduced pressure;
[0015] FIG. 5 is a schematic cross-sectional view of the apparatus
of FIG. 2 taken along line 4-4 when reduced pressure is absent from
the apparatus;
[0016] FIG. 6A is a schematic cross-sectional view of a valve in an
open position in accordance with an illustrative embodiment;
[0017] FIG. 6B is a schematic cross-sectional view of a valve in a
closed position in accordance with an illustrative embodiment;
and
[0018] FIG. 7 is a schematic graph illustrating the level of
reduced pressure over time in an apparatus for managing liquid flow
associated with a tissue site in accordance with an illustrative
embodiment.
DETAILED DESCRIPTION OF ILLUSTRATIVE EMBODIMENTS
[0019] In the following detailed description of the illustrative
embodiments, reference is made to the accompanying drawings that
form a part hereof. These embodiments are described in sufficient
detail to enable those skilled in the art to practice the
invention, and it is understood that other embodiments may be
utilized and that logical structural, mechanical, electrical, and
chemical changes may be made without departing from the spirit or
scope of the invention. To avoid detail not necessary to enable
those skilled in the art to practice the embodiments described
herein, the description may omit certain information known to those
skilled in the art. The following detailed description is,
therefore, not to be taken in a limiting sense, and the scope of
the illustrative embodiments are defined only by the appended
claims.
[0020] Referring primarily to FIG. 1, a system 100 for managing
liquid flow associated with a tissue site 103 is shown according to
an illustrative embodiment. An apparatus 106, or valve arrangement,
which is included in the system 100, manages the flow of liquid
from a liquid source 109 to the tissue site 103. The apparatus 106
may control the amount of liquid that flows to the tissue site 103,
including whether the liquid flows to the tissue site 103 at all.
The apparatus 106 uses reduced pressure from a reduced-pressure
source 115 to help manage liquid flow from the liquid source 109 to
the tissue site 103.
[0021] As used herein, "reduced pressure" generally refers to a
pressure less than the ambient pressure at a tissue site that is
being subjected to treatment. In most cases, this reduced pressure
will be less than the atmospheric pressure at which the patient is
located. Alternatively, the reduced pressure may be less than a
hydrostatic pressure at the tissue site. Unless otherwise
indicated, values of pressure stated herein are gauge pressures.
The reduced pressure delivered may be constant or varied (patterned
or random) and may be delivered continuously or intermittently.
Although the terms "vacuum" and "negative pressure" may be used to
describe the pressure applied to the tissue site, the actual
pressure applied to the tissue site may be more than the pressure
normally associated with a complete vacuum. Consistent with the use
herein, an increase in reduced pressure or vacuum pressure
typically refers to a relative reduction in absolute pressure.
Unless otherwise indicated, as used herein, "or" does not require
mutual exclusivity.
[0022] The reduced-pressure source 115 supplies reduced pressure to
the apparatus 106 via the tissue site 103. The reduced pressure may
be supplied from the reduced-pressure source 115 to the tissue site
103 through a conduit 116. Residual reduced pressure may continue
to be supplied by at least a portion 112 of the tissue site 103 to
the apparatus 106 even when the reduced-pressure source 115 is
turned off--at least until the reduced pressure in the tissue site
is disseminated. The reduced-pressure source 115 may be any device
or system that generates or provides a reduced pressure, including,
but not limited to, manually operated or powered pumps or wall
suction. As non-limiting examples, the reduced-pressure source 115
may include devices that are manually actuated, battery operated,
or any form of pneumatic pump. In one example, the pump uses low
amounts of power and is capable of operating for an extended period
of time on a single charge of the battery. As another non-limiting
example, the reduced-pressure source 115 may be wall suction. As
shown by the non-limiting examples, the possibilities for the
reduced-pressure source 115 are numerous.
[0023] The liquid source 109 supplies liquid to the tissue site 103
via the apparatus 106. The liquid source 109 may be any container,
bag, or other device capable of holding a liquid. The liquid
supplied by the liquid source 109 may be any liquid, including
liquids that contain solid particles. In one example, the liquid
supplied by the liquid source 109 may facilitate the healing or
growth of the tissue site 103. The liquid supplied by the liquid
source 109 may contain growth factors, healing factors,
antibiotics, medicines, etc.
[0024] The tissue site 103 may be the bodily tissue of any human,
animal, or other organism, including adipose tissue, muscle tissue,
dermal tissue, vascular tissue, connective tissue, cartilage,
tendons, ligaments, bone, or any other tissue. While the tissue
site 103 may include a wound (including an open wound or an
incision), diseased tissue, or defective tissue, the tissue site
103 may also be healthy tissue that is not wounded, diseased, or
defective. The application of reduced pressure to the tissue site
103 may be used to promote the drainage of exudate and other
liquids from the tissue site 103, as well as stimulate the growth
of additional tissue. In the case in which the tissue site 103 is a
wound site, the growth of granulation tissue and removal of
exudates and bacteria promotes healing of the wound. The
application of reduced pressure to non-wounded or non-defective
tissue, including healthy tissue, may be used to promote the growth
of tissue that may be harvested and transplanted to another tissue
location. The delivery of liquid from the liquid source 109 to the
tissue site 103 via the apparatus 106 may be used in conjunction
with the application of reduced pressure to the tissue site 103 to
facilitate the healing, growth, or other treatment of the tissue
site 103.
[0025] The apparatus 106 for managing liquid flow to the tissue
site 103 includes a first valve 118 in fluid communication with the
reduced-pressure source 115. In one example, fluid communication
between the first valve 118 and the reduced-pressure source 115 may
be provided, at least in part, by an intermediate reduced-pressure
conduit, or reduced-pressure conduit 121. The first valve 118 is
movable between an open position and a closed position. In an open
position, the first valve 118 may be partially or fully open, and
liquid from the liquid source 109 is allowed to pass through the
first valve 118 and into a reservoir 124 that is operable to
contain the liquid. In a closed position, the first valve 118 may
be partially or fully closed, and the first valve 118 obstructs or
prevents the flow of liquid from the liquid source 109 into the
reservoir 124.
[0026] The first valve 118 is activated, or changes flow status,
i.e., moves from the open position to the closed position or vice
versa, based on a presence or absence of reduced pressure at the
first valve 118. The reduced pressure may be transferred to the
first valve 118 from the reduced-pressure source 115 to the first
valve 118 at least in part by the reduced-pressure conduit 121. In
one example, the first valve 118 moves from a closed position to an
open position in the presence of reduced pressure at the first
valve 118, and the first valve 118 moves from an open position to a
closed position in an absence of reduced pressure at the first
valve 118. As used herein, an "absence" of reduced pressure may
include a partial or total absence of reduced pressure.
[0027] The apparatus 106 also includes a second valve 127 in fluid
communication with the reduced-pressure source 115. In one example,
fluid communication between the second valve 127 and the
reduced-pressure source 115 may be at least partially provided by
the reduced-pressure conduit 121. In the example in which the
reduced-pressure conduit 121 provides fluid communication between
the second valve 127 and the reduced-pressure source 115, the
reduced-pressure conduit 121 may be an air-permeable material, a
portion of which extends into a second delivery conduit 131. The
second valve 127 is activated, or changes flow status, i.e., moves
from an open position to a closed position or vice versa, based on
the presence or absence of reduced pressure. In an open position,
the second valve 127 may be partially or fully open, and liquid
from the reservoir 124 is allowed to pass through the second valve
127, into the second delivery conduit 131, and to the tissue site
103. In the closed position, the second valve 127 may be partially
or fully closed, and the second valve 127 obstructs or prevents the
flow of liquid to the into the second delivery conduit 131 and thus
to the tissue site 103.
[0028] In one example, the second valve 127 moves between the open
position or the closed position based on a presence of reduced
pressure at the second valve 127. In this example, the reduced
pressure may be transferred to the second valve 127 from the
reduced-pressure source 115, at least in part, by the
reduced-pressure conduit 121 and the second delivery conduit 131.
In one example, the second valve 127 moves from an open position to
a closed position in the presence of reduced pressure at the second
valve 127, and the second valve 127 moves from a closed position to
an open position in an absence of reduced pressure at the second
valve 127.
[0029] Numerous valve types may be used for the first valve 118 and
the second valve 127. In one embodiment, the first valve 118 and
the second valve 127 are pilot-actuated valves. In one example of
this embodiment, the first valve 118 and the second valve 127 may
include a master and slave cylinder, and may be made from machined
brass. In another embodiment, the first valve 118 and the second
valve 127 may be diaphragm valves.
[0030] In one embodiment, the reservoir 124 is operable to contain
a liquid and transport the liquid from the first valve 118 to the
second valve 127. The reservoir 124 may be disposed between the
first valve 118 and the second valve 127. In one non-limiting
example, a first end 125 of the reservoir 124 is coupled to the
first valve 118, and a second end 126, which is opposite the first
end 125, of the reservoir 124 is coupled to the second valve 127.
As used herein, the term "coupled" includes coupling via a separate
object, and also includes direct coupling. In the case of direct
coupling, the two coupled objects touch each other in some way. The
term "coupled" also encompasses two or more components that are
continuous with one another by virtue of each of the components
being formed from the same piece of material. Also, the term
"coupled" includes chemical coupling, such as via a chemical bond.
The term "coupled" may also include mechanical, thermal, or
electrical coupling. The term "coupled" may also include fluidly
coupled, in which case a first object that is coupled to a second
object is in fluid communication with that second object.
[0031] As shown in the illustrative embodiments disclosed herein,
the volumetric capacity of the reservoir 124 may be varied. For
example, the size of the reservoir 124 may be increased or
decreased to vary the volumetric capacity of the reservoir 124. In
one non-limiting example, the reservoir 124 may have a volumetric
capacity that corresponds to a predetermined medicinal dosage such
that the predetermine dosage of medicinal liquid is delivered to
the tissue site 103 when the second valve 127 moves to an open
position.
[0032] In one illustrative embodiment, the reservoir 124 may be
flexible, in which case the volume of the reservoir 124 may vary
depending on the amount of liquid in the reservoir 124. The
flexibility of the reservoir 124 may facilitate the movement of
liquid out of the reservoir 124. In another illustrative
embodiment, the reservoir 124 may be a rigid container. The
reservoir 124 may also include a vent line (not shown) that permits
the entry of a gas, such as air, into the reservoir 124. The vent
line may facilitate the movement of liquid out of the reservoir 124
and toward the tissue site 103. The vent line may be associated
with the liquid source 109 or a first delivery conduit 134.
Additional illustrative, non-limiting embodiments suitable for use
as the reservoir 124 are provided below in FIGS. 2-5.
[0033] In one illustrative, non-limiting embodiment, the valves
118, 127 are configured to operate according to the following TABLE
1.
TABLE-US-00001 TABLE 1 Pressure Status At Tissue Site First Valve
118 Second Valve 127 Reduced Pressure Present Open Closed Reduced
Pressure Not Present Closed Open
[0034] The position of the valves could be readily changed to be
the opposite of what is shown in TABLE 1 for the different pressure
statuses as shown in TABLE 2.
TABLE-US-00002 TABLE 2 Pressure Status At Tissue Site First Valve
118 Second Valve 127 Reduced Pressure Present Closed Open Reduced
Pressure Not Present Open Closed
[0035] At least one of the first valve 118 and the second valve 127
is in a closed position to obstruct or prevent the flow of the
liquid. In the illustrative, non-limiting example represented in
TABLE 1, the first valve 118 has one of an open position or a
closed position and the second valve 127 has the other of the open
position or the closed position such that the first valve 118 and
the second valve 127 each have different positions. When reduced
pressure is present at the tissue site 103, the reduced pressure
may be transferred to the first valve 118 and the second valve 127
by conduits 131 and 121 to cause the first valve 118 to have an
open position and the second valve 127 to have a closed position.
When the first valve 118 is in an open position and the second
valve 127 is in a closed position, liquid is allowed to move from
the liquid source 109 to the reservoir 124, but the second valve
127 obstructs or prevents the liquid from moving into conduits 121
and 131 and thus to the tissue site 103. The reservoir 124 may then
be allowed to fill to a predetermined volume, such as a
predetermined medicinal dosage.
[0036] The absence of reduced pressure at the tissue site 103 may
cause the first valve 118 to have a closed position and the second
valve 127 to have an open position. When the first valve 118 has a
closed position and the second valve 127 has an open position,
liquid is allowed to move from the reservoir 124 to the tissue site
103, but the first valve 118 obstructs or prevents the liquid from
moving to the reservoir 124 from the liquid source 109. Thus, the
predetermined volume of liquid in the reservoir 124 is delivered to
the tissue site 103 while the first valve 118 helps to prevent
additional liquid from being added to the predetermined volume of
liquid delivered from the reservoir 124.
[0037] In one embodiment, the system 100 includes the first
delivery conduit 134 that is in fluid communication with the first
valve 118, and when the first valve 118 is open, with reservoir
124. The first delivery conduit 134 is operable to deliver the
liquid from the liquid source 109 to the apparatus 106. The first
delivery conduit 134 may deliver liquid from the liquid source 109
to the reservoir 124 when the first valve 118 is in an open
position.
[0038] In one embodiment, the system 100 includes the second
delivery conduit 131 that is in fluid communication with the
reservoir 124 when the second valve 127 is in the open position.
The second delivery conduit 131 is operable to deliver liquid from
the apparatus 106 to the tissue site 103. For example, liquid may
be delivered from the reservoir 124 to the tissue site 103 via the
second delivery conduit 131. In this example, the second delivery
conduit 131 may deliver liquid from the reservoir 124 to the tissue
site 103 when the second valve 127 is in the open position.
[0039] In one illustrative embodiment, the reduced-pressure conduit
121 fluidly couples the first valve 118 and the second delivery
conduit 131. In addition, the reduced-pressure conduit 121 may
fluidly couple the first valve 118 and the second valve 127. In the
illustrative embodiment of FIG. 1, reduced pressure is delivered
through the second delivery conduit 131 to the reduced-pressure
conduit 121, which delivers the reduced pressure to the first valve
118 and the second valve 127.
[0040] In one non-limiting example, reduced pressure from the
tissue site 103 is transferred to the reduced-pressure conduit 121
by the second delivery conduit 131. The reduced-pressure conduit
121 has a first portion 140 and a second portion 137. The first
portion 140 of the reduced-pressure conduit 121 transfers reduced
pressure from the second delivery conduit 131 to the first valve
118. The second portion 137 of the reduced-pressure conduit 121
transfers reduced pressure from the second delivery conduit 131 to
the second valve 127.
[0041] In another non-limiting example, the second delivery conduit
131 may directly deliver reduced pressure from the tissue site 103
to the second valve 127 without the intervening reduced-pressure
conduit 121 (or alternatively, the second portion 137 may comprise
a portion of the second delivery conduit 131). In this non-limiting
example, the reduced-pressure conduit 121 may be in fluid
communication with the first valve 118, and may be operable to
transmit reduced pressure directly from the tissue site 103 to the
first valve 118. Also, in this non-limiting example, the
reduced-pressure conduit 121 may be fluidly coupled to the second
delivery conduit 131 or the tissue site 103.
[0042] The system 100 may also include a manifold 143 that may be
placed adjacent or in contact with the tissue site 103. The
manifold 143 may distribute the liquid received from the apparatus
106 to the tissue site 103. The manifold 143 may be a
biocompatible, porous material that is capable of being placed in
contact with the tissue site 103 and distributing reduced pressure
or liquid to the tissue site 103. The manifold 143 may be made from
foam, gauze, felted mat, or other suitable material or structure
that distributes reduced pressure. The manifold 143 may include a
plurality of flow channels or pathways to facilitate distribution
of reduced pressure or liquid to or from tissue site 101.
[0043] The manifold 143 may further serve as a scaffold for new
cell-growth, or a scaffold material may be used in conjunction with
the manifold 143 to promote cell-growth. A scaffold is a substance
or structure used to enhance or promote the growth of cells or
formation of tissue, such as a three-dimensional porous structure
that provides a template for cell growth. Illustrative examples of
scaffold materials include calcium phosphate, collagen, PLA/PGA,
coral hydroxy apatites, carbonates, or processed allograft
materials. In one example, the scaffold material has a high
void-fraction (i.e. a high content of air). In another embodiment,
the system 100 does not include the manifold 143.
[0044] By using reduced pressure from the reduced-pressure source
115, the system 100 is able to effectively manage the flow of
liquid from the liquid source 109 to the tissue site 103. Measured
dosages of liquid, such as a medicinal liquid, may be released from
the reservoir 124 to the tissue site 103 at predetermined time
intervals. For example, reduced pressure from the reduced-pressure
source 115 may be applied to the tissue site 103 in a cyclic manner
to determine when liquid is released from the reservoir 124 to the
tissue site 103. In this example, when the reduced-pressure source
115 applies reduced pressure to the tissue site 103, the reduced
pressure is transferred to the first valve 118 and the second valve
127 to cause the first valve 118 to have an open position and the
second valve 127 to have a closed position. Thus, liquid is allowed
to flow from the liquid source 109 to the reservoir 124, but is
obstructed from flowing from the reservoir 124 to the tissue site
103. When the reduced-pressure source 115 ceases to apply reduced
pressure to the tissue site 103, thereby causing an absence of
reduced pressure at the tissue site 103, the first valve 118 may
transition to a closed position and the second valve 127 transition
to an open position. Thus, a measured dosage of liquid in the
reservoir 124 is allowed to flow to the tissue site 103, and the
first valve 118 obstructs liquid from flowing into the reservoir
124 from the liquid source 109. In this manner, the reduced
pressure applied to the tissue site 103 by the reduced-pressure
source 115 may be cycled to manage the application of liquid to the
tissue site 103.
[0045] In one embodiment, a method for managing liquid flow
associated with the tissue site 103 may include receiving reduced
pressure at the first valve 118 and the second valve 127. The
reduced pressure may be received by the first valve 118 and the
second valve 127 via the reduced-pressure conduit 121 or the second
delivery conduit 131. The method may also include opening the first
valve 118 in response to receiving reduced pressure at the first
valve 118. The method may also include receiving a liquid at the
reservoir 124 in response to opening the first valve 118. The
method may also include closing the second valve 127 in response to
receiving reduced pressure at the second valve 127. The method may
also include obstructing a flow of liquid from the reservoir 124 in
response to closing the second valve 127. "Obstructing" includes
partially or fully obstructing.
[0046] In one embodiment, the method may also include closing the
first valve 118 in response to an absence of reduced pressure at
the first valve 118. The reduced-pressure source 115 may cease to
supply reduced pressure to the tissue site 103 and thus cause an
absence of reduced pressure at the first valve 118. The method may
also include obstructing the flow of liquid from the liquid source
109 to the reservoir 124 in response to closing the first valve
118. The second valve 127 may open in response to the absence of
reduced pressure at the second valve 127. The tissue site 103 may
then receive liquid from the reservoir 124 in response to opening
the second valve 127.
[0047] In another embodiment, a method for managing liquid flow
associated with the tissue site 103 may include changing a position
of the first valve 118 to one of an open position or a closed
position based on the presence of reduced pressure at the first
valve 118. The method also includes changing a position of the
second valve 127 to the other of the open position or the closed
position. The method may also include obstructing a flow of liquid
using the valve having the closed position, which, in this
embodiment, may be either the first valve 118 or the second valve
127.
[0048] In one example, changing the position of the first valve 118
to one of the open position or the closed position based on the
presence of reduced pressure at the first valve 118 includes
changing the position of the first valve 118 from the closed
position to the open position in the presence of reduced pressure.
In another example, changing the position of the first valve 118 to
one of the open position or the closed position based on the
presence of reduced pressure at the first valve 118 includes
changing the position of the first valve 118 from the open position
to the closed position in an absence of reduced pressure. In
another example, the first valve 118 is in the closed position, and
obstructing the flow of liquid using the valve having the closed
position includes obstructing the liquid from being received by the
reservoir 124 using the first valve 118. In another example, the
method may include receiving liquid at the reservoir 124 when the
first valve 118 is in the open position.
[0049] In one example, changing the position of the second valve
127 to the other of the open position or the closed position
includes changing the position of the second valve 127 from the
open position to the closed position in the presence of reduced
pressure. In another example, the second valve 127 is in the closed
position, and obstructing the flow of liquid using the valve having
the closed position includes obstructing the liquid from leaving
the reservoir 124 using the second valve 127. In another example,
changing the position of the second valve 127 to the other of the
open position or the closed position includes changing the position
of the second valve 127 from the closed position to the open
position in an absence of reduced pressure. In another example, the
method may include receiving liquid at the tissue site 103 when the
second valve 127 is in the open position.
[0050] In one embodiment, a method of manufacturing an apparatus
for managing liquid flow associated with the tissue site 103
includes providing the first valve 118, which is capable of having
an open position and a closed position based on a presence of
reduced pressure. The method also includes providing the second
valve 127, which is capable of having an open position or a closed
position based on the presence of reduced pressure. The method may
also include providing the reservoir 124, which is operable to
contain a liquid, and fluidly coupling the reservoir 124 to the
first valve 118 and the second valve 127. The reservoir 124 may be
disposed between the first valve 118 and the second valve 127.
[0051] In one example, the method of manufacturing also includes
providing the reduced-pressure conduit 121, and coupling the
reduced-pressure conduit 121 to at least one of the first valve 118
and the second valve 127. In this example, the reduced-pressure
conduit 121 is operable to transfer reduced pressure to at least
one of the first valve 118 and the second valve 127.
[0052] Referring now primarily to FIGS. 2-5, an apparatus 206, or
valve arrangement, is shown according to an illustrative
embodiment. The apparatus 206 may be used as the apparatus 106 in
the system 100 of FIG. 1. The apparatus 206 comprises a plurality
of sheets, including a first sheet 246, a second sheet 249, and a
third sheet 252, as well as a foam member 255. In one embodiment,
the first sheet 246, the second sheet 249, the third sheet 252, and
the foam member 255 may be combined (by coupling a portion,
enclosing, or other techniques) with one another to form the
various components of the apparatus 206, including the first valve
218, the second valve 227, the reservoir 224, and the
reduced-pressure conduit 221. The first valve 218, the second valve
227, the reservoir 224, and the reduced-pressure conduit 221 are
functionally analogous to the first valve 118, the second valve
127, the reservoir 124, and the reduced-pressure conduit 121 in
FIG. 1, respectively.
[0053] The first sheet 246, the second sheet 249, and the third
sheet 252 may be composed of any liquid impermeable material.
Non-limiting examples of the material from which the first sheet
246, the second sheet 249, and the third sheet 252 may be formed
include polyvinyl chloride (PVC), polyurethane (PU), polyolefins,
polyethylene (PE), polypropylene (PP), etc. In one example, the
first sheet 246, the second sheet 249, and the third sheet 252 may
formed from a flexible or rigid material. Although each of the
first sheet 246, the second sheet 249, and the third sheet 252 may
be composed of the same material, each of the first sheet 246, the
second sheet 249, and the third sheet 252 may also be composed of
different materials. For example, the third sheet 252 may be
composed of a different material than the first sheet 246 and the
second sheet 249. In one non-limiting example, the first sheet 246
and the second sheet 249 are approximately the same size and shape.
Also, the third sheet 252 may be smaller than the first sheet 246
or the second sheet 249.
[0054] The first sheet 246, the second sheet 249, the third sheet
252, and the foam member 255 may be coupled to one another in a
wide variety of ways to form the various components of the
apparatus 206. In one embodiment, the first sheet 246 may be
coupled to at least one of the second sheet 249 and the third sheet
252 along lines 258 to form the first valve 218, the second valve
227, the reservoir 224, and the reduced-pressure conduit 221. In
addition to the pattern shown in FIG. 3, the lines 258 may form any
pattern that provides desirable characteristics for the apparatus
206, including the various components thereof. In addition, the
first sheet 246 may be coupled to at least one of the second sheet
249 and the third sheet 252 at the lines 258 in any manner,
including welding (e.g., ultrasonic or RF), bonding, adhesives
(e.g., silicone adhesive), cements, etc.
[0055] In one example, the first sheet 246 may be coupled to at
least one of the second sheet 249 and the third sheet 252 to form
the reservoir 224 and the reduced-pressure conduit 221. In this
example, the first sheet 246 may be coupled to the second sheet 249
and the third sheet 252 along a portion 261 of the lines 258 to
form the reservoir 224. Thus, the reservoir 224 may be at least
partially formed by abutting portions of the first sheet 246 and
the second sheet 249 and abutting portions of the first sheet 246
and the third sheet 252. "Abutting" may mean next to each other or
near and yet spaced. In addition, the first sheet 246 may be
coupled to the second sheet 249 and the third sheet 252 along a
portion 264 of the lines 258 to form the reduced-pressure conduit
221. Thus, the reduced-pressure conduit 221 may be at least
partially formed by abutting portions of the first sheet 246 and
the second sheet 249 and abutting portions of the first sheet 246
and the third sheet 252.
[0056] The third sheet 252 may also be coupled to the second sheet
249 along lines 271 to form an inlet conduit 273. Thus, the inlet
conduit 273 may be at least partially formed by abutting portions
of the third sheet 252 and the second sheet 249. The inlet conduit
273 may transfer the liquid 250 to the reservoir 224. The inlet
conduit 273 may also include an aperture or hole 275, and the
liquid 250 may be transferred from the inlet conduit 273 to the
reservoir 224 via the hole 275. The apparatus 206 also includes a
first delivery conduit 234, which delivers the liquid 250 from a
liquid source to the inlet conduit 273. The first delivery conduit
234 is insertable into the inlet conduit 273, and may be removably
coupled to the inlet conduit 273 by any technique, including
interference fit.
[0057] The apparatus 206 also includes the foam member 255, which
may be disposed between the first sheet 246 and the second sheet
249 and at least partially enclosed therebetween. In addition or
alternatively, a portion 267 of the foam member 255 may also be
disposed between the first sheet 246 and the third sheet 252. The
foam member 255 is operable to transfer reduced pressure, which may
be from a reduced-pressure source, and the liquid 250, which may be
from a liquid source. A portion 269 of the foam member 255 may be
included between the portions of the first sheet 246 and the second
sheet 249 that form the reduced-pressure conduit 221, as well as
between the portions of the first sheet 246 and the third sheet 252
that form the reduced-pressure conduit 221. The portion 269 of the
foam member 255 may thus transfer reduced pressure through the
reduced-pressure conduit 221. In an alternative embodiment, a
portion of the foam member 255 may also be used to help form the
reservoir 224.
[0058] Although in the examples of FIGS. 2-5, the foam member 255
is composed of foam, the foam member 255 may be composed of any
material that is capable of transferring reduced pressure or the
liquid 250. The foam member 255 may be any manifold material. The
foam member 255 may also be composed of compressible materials.
[0059] With reference primarily to FIGS. 3-5, in one embodiment, a
first end 277 of the foam member 255 forms at least a portion of
the first valve 218. The first end 277 of the foam member 255 may
be an enlarged end portion, and may have any shape, including a
rectangular, circular, diamond, elliptical, or polygonal shape. In
one example, the first end 277 compresses in the presence of
reduced pressure to a compressed state 279, as shown in FIG. 4. The
first end 277 may expand back to an original size in an absence of
reduced pressure to form an expanded state 281, as shown in FIG. 5.
When the first end 277 is in the compressed state 279, the first
valve 218 is in an open position. When the first end 277 is in the
expanded state 281, the first valve 218 is in a closed position.
Thus, when the reduced-pressure conduit 221 transfers reduced
pressure to the first end 277, which forms part of the first valve
218, the first end 277 compresses to create a space 283 through
which the liquid 250 may flow. In particular, the liquid 250 may
flow from the first delivery conduit 234 and into the reservoir 224
via the hole 275, as indicated by arrows 284. Conversely, when
reduced pressure is absent at the first end 277, the first end 277
is in the expanded state 281 to reduce or eliminate the space 283,
and the liquid 250 is obstructed from flowing from the first
delivery conduit 234 into the reservoir 224.
[0060] The apparatus 206 also includes the second valve 227, which
may be at least partially formed by a first wall 285 and the second
wall 287. The first wall 285 may be a portion of the first sheet
246, and the second wall 287 may be a portion of the second sheet
249. In one example, the first wall 285 and the second wall 287 are
drawn nearer to one another in the presence of reduced pressure to
form a closed position, as shown in FIG. 4. In this example, the
first wall 285 and the second wall 287 may firmly abut one another
to form the closed position. The first wall 285 and the second wall
287 may also move away from one another in an absence of reduced
pressure to form an open position, as shown in FIG. 5. In the open
position, a space 289 exists between the first wall 285 and the
second wall 287 to allow the liquid 250 in the reservoir 224 to
flow out of the reservoir 224 and into the second delivery conduit
231, as indicated by arrows 291. The second delivery conduit 231
may then deliver the liquid 250 to a tissue site.
[0061] When the second valve 227 is in the open position, the
liquid 250 may pass through a second end 292 of the foam member
255. In addition, the movement of the first wall 285 away from the
second wall 287 in the absence of reduced pressure may be assisted
by the second end 292 of the foam member 255. The second end 292 of
the foam member 255 may be an enlarged end portion 293. The second
end 292 of the foam member 255 may bias the first wall 285 away
from the second wall 287. Thus, the second end 292 of the foam
member 255 assists in opening the second valve 227 in the absence
of reduced pressure at the second valve 227.
[0062] The apparatus 206 may also include a set of restriction
strips, e.g., 294, 295, and 296. The set of restriction strips may
include one or more restriction strips. The set of restriction
strips 294, 295, and 296 are disposed over at least a portion of
the reservoir 224. The set of restriction strips 294, 295, and 296
are operable to restrict expansion of the reservoir 224 to contain
a maximum amount of the liquid 250. Each of the set of restriction
strips 294, 295, and 296 is removable from the reservoir 224 to
increase the maximum amount of the liquid 250 that may be held by
the reservoir 224. To provide one non-limiting example, the
reservoir 224 may be able to hold 10 milliliters of the liquid 250
when restriction strips 294, 295, and 296 are applied to the
reservoir 224. Restriction strip 294 may be removed from the
reservoir 224 to increase the maximum amount of the liquid 250 that
is holdable by the reservoir 224 to 15 milliliters. Restriction
strip 295 may be removed from the reservoir 224 to increase the
maximum amount of the liquid 250 that is holdable by the reservoir
224 to 20 milliliters. In addition, all of the restriction strips
294, 295, and 296 may be removed from the reservoir 224, in which
case the reservoir 224 may be allowed to expand to a maximum
capacity. While specific illustrative examples are provided, i.e.,
10 milliliters, 15 milliliters, and 20 milliliters, it should be
understood that any volume may be used for the reservoir 224 and
the volume provided with restriction strips 294, 295, 296.
[0063] In another embodiment, the apparatus 206 may include a
column (not shown) that is slidably coupled to the reservoir 224.
The column may be slidable into a plurality of positions, and may
be slidable along the length, width, or thickness of the reservoir
224. The position of the column determines a maximum amount of the
liquid 250 that may be held by the reservoir 224. In one example of
this embodiment, the reservoir 224 may be a syringe that has a
valve on each end. The syringe may also include an internal
slidable column.
[0064] In operation according to one embodiment, reduced pressure
may be applied to the apparatus 206 to change the positions of the
first valve 218 and the second valve 227, and thereby manage the
flow of the liquid 250 to a tissue site. In FIG. 4, reduced
pressure is transmitted from a reduced-pressure source, such as the
reduced-pressure source 115 in FIG. 1, to the first valve 218 and
the second valve 227 via the reduced-pressure conduit 221. The
reduced pressure may be transmitted from the reduced-pressure
source 115 via a tissue site. As shown in FIG. 4, the first valve
218 has an open position in the presence of reduced pressure at the
first valve 218, and the second valve 227 has a closed position in
the presence of reduced pressure at the second valve 227. Thus, in
FIG. 4, the reservoir 224 receives the liquid 250 from a liquid
source, and the second valve 227 obstructs the liquid 250 from
flowing out of the reservoir 224. The set of restriction strips
294, 295, and 296 may restrain the expansion of the reservoir 224
such that the reservoir 224 is able to hold a predetermined maximum
amount of the liquid 250. In one example, this predetermined
maximum amount may be a prescribed dosage.
[0065] In FIG. 5, little or no reduced pressure is transferred from
a reduced-pressure source to the first valve 218 and the second
valve 227 via the reduced-pressure conduit 221. As result, as shown
in FIG. 5, the first valve 218 has a closed position to obstruct
the flow of the liquid 250 into the reservoir 224, and the second
valve 227 has an open position to allow the liquid 250 to flow from
the reservoir 224 to a tissue site. The valves 218 and 227 could be
structured to open and close opposite to that described.
[0066] Referring now primarily to FIGS. 6A and 6B, a second valve
627, which may be used as the second valve 227 in FIG. 2, is shown
according to an illustrative embodiment. In FIG. 6A, the second
valve 627 is shown in an open position. In FIG. 6B, the second
valve 627 is shown in a closed position. The second valve 627
includes spacers 697 and 698. In an absence of reduced pressure at
the second valve 627, the spacers 697 and 698 bias the first wall
685 away from the second wall 687 to form the space 689. The
spacers 697 and 698 may be composed of any elastic resilient
material that is either formed with apertures or is liquid
permeable.
[0067] Referring now primarily to FIG. 7, a schematic graph 700
illustrating the level of reduced pressure over time in an
apparatus, such as apparatus 106 in FIG. 1 or apparatus 206 in FIG.
2, for managing liquid flow associated with a tissue site is
depicted in accordance with an illustrative embodiment. During time
period 704, reduced pressure is applied to the apparatus for
managing liquid flow. The reduced pressure may be supplied by a
tissue site, which, in turn, receives reduced pressure from a
separate reduced-pressure device or source, e.g., the
reduced-pressure source 115 in FIG. 1, which may include a
controller. Thus, in this example, the separate reduced-pressure
device is turned on during time period 704.
[0068] During time period 704, the reduced pressure is transferred
to a first valve and a second valve, such as a first valve and a
second valve described in any of the illustrative embodiments.
During time period 704, the first valve is in an open position and
the second valve is in a closed position such that a reservoir, as
described in any of the illustrative embodiments, fills with a
liquid from a liquid source up to a predetermined or maximum
volume. The liquid, however, is obstructed from exiting the
reservoir and flowing to a tissue site during the time period
704.
[0069] During the time period 705, the separate reduced-pressure
source that supplies reduced pressure to the tissue site may be
turned off, or may supply a relatively lesser amount of reduced
pressure than during the time period 704. During the time period
705, the absence of reduced pressure at the first valve and the
second valve causes the first valve to have a closed position and
the second valve to have an open position. Thus, during the time
period 705, the volume of liquid in the reservoir is allowed to
exit the reservoir and flow to a tissue site. In one non-limiting
example, the reduced pressure may be oscillated between the reduced
pressure in the time period 704 and the reduced pressure in the
time period 705 so that the flow of liquid to a tissue site may be
managed in measured doses. In this example, the reduced pressure
supplied by the separate reduced-pressure source to the tissue site
may be turned off and on in predetermined time internals, such as
the time period 704 and the time period 705.
[0070] Although the present invention and its advantages have been
disclosed in the context of certain illustrative, non-limiting
embodiments, it should be understood that various changes,
substitutions, permutations, and alterations can be made without
departing from the scope of the invention as defined by the
appended claims. It will be appreciated that any feature that is
described in a connection to any one embodiment may also be
applicable to any other embodiment.
* * * * *